key: cord-0759154-df99f55g authors: Giubbini, Raffaele; Pieri, Pierluigi; Sambuceti, Gianmario title: In Memoriam: Eugenio Inglese 1945–2020 date: 2020-05-11 journal: J Nucl Cardiol DOI: 10.1007/s12350-020-02148-7 sha: 1cbd753b8ad2a05bca2231c478bcee1b62e8d118 doc_id: 759154 cord_uid: df99f55g nan In Memoriam Eugenio Inglese, MD (1945 -2020 The cardiology and nuclear medicine communities are saddened by the passing of Eugenio Inglese, MD, who died on 21 March 2020, victim of coronavirus pandemic. It is hard to write an obituary, it is hard to find the right words to describe a sentiment of a loss of friend and esteemed scientist. Prof. Inglese was born in Alessandria, in Northern Italy, and received his undergraduate medical education at the University of Pavia. He completed his nuclear medicine fellowship at the University of Milan in 1979. After that he got the postgraduate degree in cardiology. He spent the first 10 years of his professional activity at the Ospedale Niguarda in Milan where he started his work in the field of nuclear cardiology using a mobile gamma-camera in an Italian leading center for cardiovascular diseases (A. De Gasperis Centre). In 1990 he became chief of the nuclear medicine department of the Ospedale Maggiore in Novara, that he headed for 20 years; he was promoted to associate professor of medical imaging. In 2008 something happened that modified his enthusiasm for life: Eugenio mourned the loss of his son Carlo due to a road traffic accident. Eugenio was co-founder of the Italian Working Group of Nuclear Cardiology and a leader, a guide and an enthusiastic teacher for many young Italian physicians for decades. As associate professor of diagnostic imaging, he chaired a postgraduate Master course on telecommunication and distant learning in medicine. The Italian Association of Nuclear Medicine (AIMN) identified his laboratory as a Centre of excellence for training fellows in nuclear cardiology. His interests covered the gamut of activities in the field, from PET/CT in oncology and radiotherapy, to image fusion, but he is best known for his work on myocardial perfusion imaging. His laboratory served as the core site in multicenter studies for the use of 201-Tl in viability evaluation. 1, 2 In the eighties, he was involved in several multicenter trials on the use of Tc-labeled radiopharmaceuticals. [3] [4] [5] [6] He combined creativity, and meticulous evaluation in the development of new applications in his field, yet he never forgot that the ultimate purpose of science was to promote the care of individual patients. Despite his knowledge and his position at the forefront of the development of nuclear medicine, he was always very kind, humble and open to discussions with colleagues at national and international level. Beyond his remarkable scientific production, we remember his clear contributions during our scientific meetings, example of intellectual clarity and scientific rigor, aimed to contribute to the diffusion of Nuclear Cardiology in Italy. He was a great friend for many of us and we are sure to represent the sentiments of all Italian and many international nuclear cardiology physicians. Assessment of myocardial viability after thallium-201 reinjection or rest-redistribution imaging: A multicenter study. The Italian Group of Nuclear Cardiology A multicenter trial on interobserver and intraobserver reproducibility of segmentalscoring of thallium 201 planar myocardial imaging before and after reinjection. Italian Group of Nuclear Cardiology Maldistribution of regional myocardial perfusion at rest in patients with coronary artery disease and no previous myocardial infarction, evidenced by 99mTc-Sestamibi scintigraphy Accuracy and safety of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (Sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: A multicenter study. Italian Group of Nuclear Cardiology European multi-centre comparison of thallium 201 and technetiumm methoxyisobutylisonitrile in ischaemic heart disease Sensitivity of 99mTc Hexakis 2-methoxyisobutyl isonitrile (99mTc-Sestamibi) at rest and during exercise for detection of coronary artery disease and comparison with 201TI: A multicenter study